Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Buy Out

<< Previous

Bullboard Posts

Next >>

Comment by Canada2016on Apr 10, 2021 6:01pm

241 Views

Post# 32973313

RE:RE:RE:Buy Out

Haha mention the possibility and here them come out of the woodwork all this negativity proves the possibility that's what happens before a buyout and math is correct kid 7 million shares x 2.87 roughly under 21 mill 7 mill x 1.50 10.5 mill simple math and didn't sell a share and keep calling names behind the internet and I will contact my lawyer for harassment

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec